Front-line drug for ulcerative colitis found to have additional mechanism of action that until now remained elusive

Front-line drug for ulcerative colitis found to have additional mechanism of action that until now remained elusive

Monoclonal antibodies have become indispensable in medicine to combat cancers, infectious diseases and autoimmune disorders. But the mechanism of action of a major monoclonal antibody developed for ulcerative colitis has remained elusive—until now.

​Medical Xpress – latest medical and health news stories

Read More

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *